Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget Start Printed Page 52440(OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Fax written comments on the collection of information by September 7, 2016.
To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or emailed to firstname.lastname@example.org. All comments should be identified with the title Outcomes Evaluation Survey for Graduates of the FDA Commissioner's Fellowship Program. Also include the FDA docket number found in brackets in the heading of this document.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
End Further Info
Start Supplemental Information
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
Survey of Alumni Commissioner's Fellowship Program Fellows—OMB Control Number 0910-NEW
FDA is requesting approval from the Office of Management and Budget to gather information from Alumni Commissioner's Fellowship Program (CFP) Fellows. The information from Alumni CFP Fellows will allow FDA's Office of the Commissioner (OC) to easily and efficiently elicit and review program feedback. The online survey will assist the Agency in promoting and protecting the public health by encouraging outside persons to share their experience with the FDA while a Commissioner's Fellow. The process will reduce the time and cost of submitting written documentation to the Agency and lessen the likelihood of surveys being misrouted within the Agency mail system. The information gathered by the survey will be used to gain insights into, and to document, impacts that the CFP has had and is having on former CFP fellows and contributions and impacts that the former fellows are making in their current work. The surveys include questions to assess the following measures: Post-fellowship employment (e.g., employment type); number of awards; number of contributions while a CFP fellow (e.g., number of publications, guidances authored or co-authored); and contributions in their field (e.g., list of publications).
In the Federal Register of February 24, 2016 (81 FR 9202), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received.
FDA estimates the burden of this collection of information as follows:
Table 1—Estimated Annual Reporting Burden 1
|Activity||Number of respondents||Number of responses per respondent||Total annual responses||Average burden per response||Total hours|
|Fellowship Program Survey||35||1||35||0.50 (30 minutes)||17.5|
|1 There are no capital costs or operating maintenance costs associated with this collection of information.|
FDA based these estimates on the number of fellows that have graduated and left the Agency over the past 5 years.
End Supplemental Information
Dated: August 2, 2016.
Associate Commissioner for Policy.
[FR Doc. 2016-18711 Filed 8-5-16; 8:45 am]
BILLING CODE 4164-01-P